CME Group Inc (NASDAQ: CME)’s stock price has decreased by -0.74 compared to its previous closing price of 269.50. However, the company has seen a -0.31% decrease in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-13 that Markets are chaotic, headlines rule, and short-term forecasts are pointless. That’s why I focus on long-term dividend investing with wide-moat stocks. In this environment, I’m doubling down on two of my favorite dividend stocks, which are built for uncertainty, strong cash flow, and dependable dividends. With long-term conviction, I keep using market weakness to add to these holdings. I’m sticking to this playbook for compounding success.
Is It Worth Investing in CME Group Inc (NASDAQ: CME) Right Now?
The price-to-earnings ratio for CME Group Inc (NASDAQ: CME) is 26.89x, which is above its average ratio. Moreover, the 36-month beta value for CME is 0.47. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 3 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CME is 359.24M and currently, short sellers hold a 1.39% of that float. On June 17, 2025, CME’s average trading volume was 2.56M shares.
CME’s Market Performance
CME’s stock has seen a -0.31% decrease for the week, with a -2.37% drop in the past month and a 1.49% gain in the past quarter. The volatility ratio for the week is 0.96%, and the volatility levels for the past 30 days are at 1.14% for CME Group Inc The simple moving average for the past 20 days is -3.79% for CME’s stock, with a 10.42% simple moving average for the past 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Morgan Stanley repeating the rating for CME by listing it as a “Overweight.” The predicted price for CME in the upcoming period, according to Morgan Stanley is $301 based on the research report published on April 08, 2025 of the current year 2025.
Raymond James, on the other hand, stated in their research note that they expect to see CME reach a price target of $287. The rating they have provided for CME stocks is “Outperform” according to the report published on March 10th, 2025.
Citigroup gave a rating of “Neutral” to CME, setting the target price at $250 in the report published on January 06th of the current year.
CME Trading at -1.73% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.01% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from Carey Charles P, who sale 500 shares at the price of $265.35 back on Jun 10 ’25. After this action, Carey Charles P now owns 4,900 shares of CME Group Inc, valued at $132,676 using the latest closing price.
Carey Charles P, the Director of CME Group Inc, proposed sale 500 shares at $286.37 during a trade that took place back on May 28 ’25, which means that Carey Charles P is holding shares at $143,185 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.65 for the present operating margin
- 0.86 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.11. Equity return is now at value 13.40, with 2.50 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.14. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 25.08.
Currently, EBITDA for the company is 4.61 billion with net debt to EBITDA at 0.4. When we switch over and look at the enterprise to sales, we see a ratio of 15.66. The receivables turnover for the company is 8.16for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
To wrap up, the performance of CME Group Inc (CME) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
